Skip to content

Formula Suggestions

Let us know which new formula you would like to see included in MedCalc or how we can enhance existing formulas.

145 results found

  1. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  2. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  3. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  4. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  5. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  6. Escala PORT

    -Idade >65 anos: 1 ponto
    -Obesidade (superior a 150% do peso ideal corporal): 1 ponto
    -Local da cirurgia: Tórax 2 pontos/Abdome alto 2 pontos/outro local 1 ponto
    -Histórico pulmonar: fumante ativo 1 ponto/tosse ou expectoração 1 ponto/ Doença pulmonar 1 ponto
    -Espirometria: CVF <50% 1 ponto// VEF1/CVF 65% a 74,9% 1 ponto// VEF1/CVF 50% a 64,9% 2 pontos// VEF1/CVF <50% 3 pontos

    Baixo risco: 0-3 pontos; morbidade 6%, mortalidade 2%.
    Moderado risco: 4 - 6 pts; 23% morbidade, 6% mortalidade
    Alto risco: 7 - 11 pontos; 35% morbidade, 12% mortalidade

    Chest, 1988; 93:946-51

    1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  7. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  8. STESS

    Orienta sobre la mortalidad en status epiléptico

    1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  9. Sdai

    Es la simplificada de evaluación de artritis reumatoidea

    1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  10. VH-V8

    Evaluación de la vejiga neurogenica

    1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  11. Meessi-AHF

    MEESSI-AHF is a risk model to predict 30-day mortality in patients attending Emergency Departments (ED) with a diagnosis of Acute Heart Failures (AHF).

    The MEESSI-AHF score was derived on 4867 consecutive AHF patients admitted to Spanish ED during 2009-2011, and then validated in 3229 consecutive AHF patients during 2014. (Note patients also with ST elevation myocardial infarction are excluded)

    The MEESSI-AHF risk model includes 13 variables readily available on arrival to Emergency Department. The 40% of patients classified as LOW RISK (30-day mortality: <2%) should be considered as potential candidates to be early discharged from Emergency Department without admission after…

    7 votes
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  12. pH to H+ converter

    Here in the UK different hospitals use either pH or H+ on the ABG analysers. Would be useful to add pH to H+ and vice versa converter to units formula

    1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  13. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  14. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  15. ICDSC

    the Intensive Care Delirium Screening Checklist

    4 votes
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  16. 1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  17. Homeostatic Model Assessment of Insulin Resistance (HOMA-IR, HOMA-beta)

    The HOMA-IR is a measure of insulin resistance (the homeostatic model also can assess beta cell function. There are various ways to calculate
    glucose * insulin / 405 (glucose in mg/dl)= HOMA-IR
    360 * insulin]/[glucose] - 63)% glucose in mg/dl = HOMA-BETA (% beta cell function)
    Look up HOMA-IR on google. MedCalX has it. Someplace connected with Oxford in England has a computer-based calculation

    2 votes
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  18. Add Brooke to Parkland

    It would be nice to have parkland and brooke formulas

    6 votes
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  19. 47 votes
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  20. PESI - OTPE

    Il serait bien de compléter le score PESI avec le risque de mortalité à 1 mois par classe
    Out-patient Treatment for Pulmonary Embolism
    Classe 1 : 0-1,6%
    Classe 2 : 1,7-3,5%
    Classe 3 : 3,2-7,1%
    Classe 4 : 4-11%
    Classe 5 : 10-24,5%

    1 vote
    Vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    You have left! (?) (thinking…)
    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  • Don't see your idea?

Formula Suggestions

Categories

Feedback and Knowledge Base